Gender-specific medical treatment is a new medical treatment that has been spreading mainly around the US since 1990, in which medical treatment is carried out keeping in mind the differences in the disease occurrence and condition due to the various differences between men and women. Conventionally, medical care considers men and women as the same. Until now, since men were considered the standard for medical treatment, often various medical data were obtained from men, which were used unaltered for the medical treatment of women. However, it has become clear that there are gender differences in risk factors and symptoms for the same disease. Thus, gender-specific medicine is to consider the differences between men and women and reflect those differences in the best medical care based on the evidence.
In the US, creation of a system that promotes medical care, based on the differences between men and women (gender difference) in various aspects, has begun, and the guidelines for preventing cardiovascular diseases in women have also been published by the American College of Cardiology. In Japan, compared to the US, studies that consider gender differences have not progressed sufficiently so far.
Bearing in mind the lack of treatment differentiation in Japan, with the cooperation of the hospitals providing cardiovascular care in Japan, our purpose is to study the influence of gender differences on arteriosclerotic diseases (such as myocardial infarction or cerebral infarction) and the onset, progress and prognosis of arteriosclerotic diseases in women from medical and social aspects and to clarify the relevant factors.
It should be noted that the recruitment of participants for this study is closed, and data analysis is in progress.